Published in AIDS Weekly, July 10th, 1995
The acyclic nucleoside analog 1-[(2-hyroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) and its derivatives are potent inhibitors of HIV-1. Like the diverse group of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs), most HEPT derivatives inhibit HIV-1, but not HIV-2, reverse transcriptase (RT). In fact, HEPT and the NNRTIs are sometimes referred to as HIV-1-specific RT inhibitors. But in addition to NNRTI-like noncompetitive RT inhibition, the HEPT compounds also inhibit HIV RT by competing with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.